SEC Form 4 · accession 0001144204-17-032807
NORTHWEST BIOTHERAPEUTICS INC · NWBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alton L Boynton
Officer — Chief Scientific Officer · Director
Period of report
Jun 13, 2017
Accepted (ET)
Jun 15, 2017 · 9:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001072379
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.25 | Jun 13, 2017 | A | 3,402,935 | A | — | Jun 13, 2022 | Common Stock | 3,402,935 | 3,402,935 | D |
Explanation of responses
- F1The option's vesting schedule is as follows: 50% vested upon the date of grant with the remaining 50% vesting over a 24-month period in equal monthly installments